Journal
JOURNAL OF FUNGI
Volume 7, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/jof7060456
Keywords
paediatric fungal infections; antifungal treatment; therapeutic drug monitoring; voriconazole; children; inflammation
Categories
Funding
- Pfizer [WI182544]
Ask authors/readers for more resources
Voriconazole plasma concentrations in children are highly variable, especially in patients aged 5-12 years. The new dosing recommendations have led to an increased rate of adequate PC in therapeutic drug monitoring, but still a portion falls outside the therapeutic range. Factors influencing PC include severe hypoalbuminemia and elevated C-reactive protein levels.
Voriconazole plasma concentrations (PC) are highly variable, particularly in children. Dose recommendations in 2-12-year-old patients changed in 2012. Little data on therapeutic drug monitoring (TDM) after these new recommendations are available. We aimed to evaluate voriconazole monitoring in children with invasive fungal infection (IFI) after implementation of new dosages and its relationship with safety and effectiveness. A prospective, observational study, including children aged 2-12 years, was conducted. TDM was performed weekly and doses were changed according to an in-house protocol. Effectiveness, adverse events, and factors influencing PC were analysed. A total of 229 PC from 28 IFI episodes were obtained. New dosing led to a higher rate of adequate PC compared to previous studies; still, 35.8% were outside the therapeutic range. In patients aged < 8 years, doses to achieve therapeutic levels were higher than recommended. Severe hypoalbuminemia and markedly elevated C-reactive protein were related to inadequate PC. Therapeutic PC were associated with drug effectiveness and safety. Higher doses in younger patients and a dose adjustment protocol based on TDM should be considered. Voriconazole PC variability has decreased with current updated recommendations, but it remains high and is influenced by inflammatory status. Additional efforts to control inflammation in children with IFI should be encouraged.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available